KALA BIO, Inc. (KALA)
(Delayed Data from NSDQ)
$5.85 USD
+0.10 (1.74%)
Updated Aug 9, 2024 02:29 PM ET
After-Market: $5.92 +0.07 (1.20%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Brokerage Reports
KALA BIO, Inc. [KALA]
Reports for Purchase
Showing records 261 - 280 ( 367 total )
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
3Q19 Financial Results Reported; Reiterate Buy; Lowering PT to $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials Uneventful; Potentially Transformational Ph3 Dry Eye Data Q1:20
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L